
Ipsen
Ipsen SA engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.
Market cap
$9.4b
Enterprise value
$9.1b
Share price
€101.10 IPN.PA
Recent deals
No columns specified
Ipsen SA engages in the research, development, manufacture, and sale of pharmaceutical products worldwide.